J&J tops by a penny in Q3 on strong sales jump

MichaelBaron

NEW YORK (CBS.MW) -- Johnson & Johnson
JNJ, -1.27%
reported third-quarter earnings of $2.1 billion, or 69 cents per share, a penny ahead of the average estimate of 19 analysts polled by Thomson First Call. In the same period a year earlier, the New Brunswick, N.J., healthcare products giant earned $1.73 billion, or 57 cents per share. Sales jumped 15.2 percent in the latest three months to $10.5 billion from $9.1 billion in the same period a year earlier. The Dow component said it saw strong performances from a number of its business units, and that its Cypher coronary stent performed well in its first full quarter. The stock closed Monday at $49.79, up 1.1 percent.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.